A phase 3, prospective, open, pilot, monocentric study to evaluate the effect of sulodexide administered at registered dose on morphology and functional properties of the venous endothelium in patients with chronic venous insufficiency.
Latest Information Update: 29 Sep 2016
At a glance
- Drugs Sulodexide (Primary)
- Indications Venous insufficiency
- Focus Pharmacodynamics
- Sponsors Alfa Wassermann SpA
Most Recent Events
- 29 Sep 2016 New trial record